Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Atyr Pharma Inc (LIFE)

Atyr Pharma Inc (LIFE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 172,922
  • Shares Outstanding, K 16,920
  • Annual Sales, $ 10,460 K
  • Annual Income, $ -16,220 K
  • 60-Month Beta 2.00
  • Price/Sales 16.69
  • Price/Cash Flow N/A
  • Price/Book 2.19
Trade LIFE with:

Options Overview

Details
  • Implied Volatility 156.15%
  • Historical Volatility 186.82%
  • IV Percentile 91%
  • IV Rank 55.05%
  • IV High 224.73% on 09/13/21
  • IV Low 72.17% on 05/11/21
  • Put/Call Vol Ratio 0.42
  • Today's Volume 3,440
  • Volume Avg (30-Day) 6,500
  • Put/Call OI Ratio 0.63
  • Today's Open Interest 7,261
  • Open Int (30-Day) 7,622

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate -0.50
  • Number of Estimates 3
  • High Estimate -0.23
  • Low Estimate -0.67
  • Prior Year -0.68
  • Growth Rate Est. (year over year) +26.47%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.59 +122.66%
on 08/23/21
12.97 -21.20%
on 09/14/21
+5.63 (+122.66%)
since 08/20/21
3-Month
4.18 +144.50%
on 06/21/21
12.97 -21.20%
on 09/14/21
+5.72 (+127.11%)
since 06/18/21
52-Week
2.93 +248.81%
on 10/28/20
12.97 -21.20%
on 09/14/21
+5.91 (+137.12%)
since 09/18/20

Most Recent Stories

More News
aTyr Pharma Announces Closing of $86.3 Million Public Offering Including Full Exercise of Underwriters' Option to Purchase Additional Shares

aTyr Pharma, Inc. (Nasdaq: LIFE), a clinical stage biotherapeutics company engaged in the discovery and development of innovative medicines based on novel biological pathways, today announced the closing...

LIFE : 10.22 (-0.87%)
Love Hemp Group PLC Announces Change of Registered Office

one of the UK's leading CBD and hemp product suppliers, announces that it has changed its registered office to Suite 1, 15 Ingestre Place, London, W1F 0DU from 14 September 2021.

WRHLF : 0.0325 (-4.41%)
LIFE : 10.22 (-0.87%)
Why Pharmaceutical Companies in Ovarian Cancer Drugs Market are Betting Big on R&D - Financial News Media

Palm Beach, FL - September 17, 2021 – FinancialNewsMedia.com News Commentary – The ovarian cancer drugs market consists of sales of ovarian cancer drugs to treat ovarian cancer. Ovarian cancer is caused...

BIOV.CN : 0.490 (-9.26%)
BVAXF : 0.3907 (-7.77%)
LPTX : 2.77 (+4.53%)
PHIO : 2.13 (-6.58%)
LIFE : 10.22 (-0.87%)
ELOX : 1.7900 (-4.28%)
Why Pharmaceutical Companies in Ovarian Cancer Drugs Market are Betting Big on R&D

, /PRNewswire/ -- - The ovarian cancer drugs market consists of sales of ovarian cancer drugs to treat ovarian cancer. Ovarian cancer is caused due to abnormal growth of cells in ovary. This industry...

BIOV.CN : 0.490 (-9.26%)
BVAXF : 0.3907 (-7.77%)
LPTX : 2.77 (+4.53%)
PHIO : 2.13 (-6.58%)
LIFE : 10.22 (-0.87%)
ELOX : 1.7900 (-4.28%)
Love Hemp Receives Initial Amazon Order

one of the UK's leading CBD and hemp product suppliers, is pleased to announce that it has received its initial order from Amazon.

LIFE.LN : 4.963 (-1.86%)
WRHLF : 0.0325 (-4.41%)
LIFE : 10.22 (-0.87%)
aTyr Pharma to Present at the Oppenheimer Fall Healthcare Life Sciences and MedTech Summit

aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel biological pathways, today announced that Sanjay S. Shukla, M.D.,...

LIFE : 10.22 (-0.87%)
aTyr Pharma Announces Pricing of $75 Million Public Offering of Common Stock

aTyr Pharma, Inc. (Nasdaq: LIFE), a clinical stage biotherapeutics company engaged in the discovery and development of innovative medicines based on novel biological pathways, today announced the pricing...

LIFE : 10.22 (-0.87%)
aTyr Pharma Announces Proposed Public Offering of Common Stock

aTyr Pharma, Inc. (Nasdaq: LIFE), a clinical stage biotherapeutics company engaged in the discovery and development of innovative medicines based on novel biological pathways, today announced that it has...

LIFE : 10.22 (-0.87%)
aTyr (LIFE) Surges on Positive Data on Lead Candidate ATYR1923

aTyr Pharma (LIFE) soars following the announcement of positive results from its phase Ib/IIa study of its lead candidate, ATYR1923, for pulmonary sarcoidosis.

REGN : 640.89 (-1.69%)
LIFE : 10.22 (-0.87%)
MRNA : 423.33 (-1.56%)
RGEN : 306.05 (-0.28%)
aTyr Pharma Announces Positive Data from Phase 1b/2a Clinical Trial Demonstrating Consistent Dose Response for ATYR1923 in Pulmonary Sarcoidosis

Trial met primary endpoint, ATYR1923 was safe and well-tolerated.

LIFE : 10.22 (-0.87%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

aTyr Pharma, Inc. is a bio-therapeutics company. The Company is involved in the discovery and development of medicines for severe, rare diseases of physiological modulators. aTyr Pharma, Inc. is a based in SAN DIEGO, United States.

See More

Key Turning Points

3rd Resistance Point 11.54
2nd Resistance Point 11.09
1st Resistance Point 10.66
Last Price 10.22
1st Support Level 9.78
2nd Support Level 9.33
3rd Support Level 8.90

See More

52-Week High 12.97
Last Price 10.22
Fibonacci 61.8% 9.13
Fibonacci 50% 7.95
Fibonacci 38.2% 6.77
52-Week Low 2.93

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar